Thinking and Memory Problem Research Study For Those With Parkinson’s Disease

Research Center: Imaging Endpoints
Location: 9977 N. 95th street, Suite 101 Scottsdale, AZ 85258
Lead Doctor: Dr. Allan M. Block
IRB Committee: This study has been reviewed and approved by WIRB-Copernicus Institutional Review Board

Background

Living with Parkinson’s disease can be a struggle. To add to the physical challenges of the disease, problems with thinking and memory can also arise. These thinking and memory problems are called mild cognitive impairment. It can affect 15% to 25% of newly diagnosed Parkinson’s patients. 

This study seeks to evaluate the effectiveness of an investigational medication that may help people with mild cognitive impairment linked with Parkinson’s disease. 

Why Participate? 

  • Participants may experience improvements to their thinking and memory problems.
  • Participants may be able to manage symptoms of mild cognitive impairment.
  • Participants will be compensated for their time and travel.
  • Participants will be helping to advance medical research on Parkinson’s Disease.

Your Rights

  • If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
  • Your records relating to this study and any other information received will be kept strictly confidential, except as required by the law.
  • Qualified health professionals will monitor your health as it relates to the study.

Who Can Participate?

  • Must be diagnosed with Parkinson’s disease.
  • Must be aged 50 to 85 years old.
  • Must be diagnosed with mild cognitive impairment associated with Parkinson’s disease (have symptoms such as having a hard time paying attention, difficulties with problem-solving, slowed thinking and issues with short-term memory), have mild dementia or have been diagnosed with mild dementia.
  • Must have a study partner to assist them during the study.
    • A study partner is someone who has frequent contact with the study participant and is willing and able to provide information about the participant and attend some study visits.
  • Able to attend 7 study visits at the research site over approximately 14 weeks as well as answer 3 study-related phone calls.

What Next?

  1. Click the link below to enter your contact details and answer some eligibility questions.
  2. The research centre will then contact you by phone to discuss the trial and answer your questions.
Click Here to Enter Your Contact Details and Be Contacted by Phone About the Trial